Galapagos NV (AMS:GLPG)
24.60
-0.06 (-0.24%)
Apr 15, 2026, 5:35 PM CET
Galapagos NV Employees
Galapagos NV had 558 employees as of June 30, 2025.
Employees
558
Change
n/a
Growth
n/a
Revenue / Employee
€1,579,898
Profits / Employee
€455,801
Market Cap
1.62B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Arcadis NV | 31,361 |
| Signify | 26,581 |
| Havas | 23,000 |
| Fugro | 9,062 |
| Basic-Fit | 7,906 |
| AMG Critical Materials | 3,640 |
| Corbion | 2,441 |
| Flow Traders | 635 |
Galapagos NV News
- 15 days ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 15 days ago - Galapagos NV: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten
- 15 days ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 20 days ago - Galapagos NV: Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - Finanz Nachrichten
- 20 days ago - Galapagos NV: Galapagos Announces Nomination of Gino Santini to its Board of Directors - Finanz Nachrichten
- 20 days ago - Galapagos Announces Nomination of Gino Santini to its Board of Directors - GlobeNewsWire
- 20 days ago - Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - GlobeNewsWire
- 23 days ago - Galapagos NV: Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten